ALGS vs BIIB: Which Stock is Better?
Side-by-side comparison of Aligos Therapeutics Inc and Biogen Inc in 2026
ALGS
Aligos Therapeutics Inc
$6.00
BIIB
Biogen Inc
$189.28
Key Metrics Comparison
| Metric | ALGS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $36.94M | $28.53B | BIIB |
| P/E Ratio | N/A | 20.92 | BIIB |
| EPS (TTM) | $N/A | $9.29 | BIIB |
| Revenue Growth | -0.7% | -0.1% | BIIB |
| Gross Margin | -3077.2% | 78.9% | BIIB |
Analyze ALGS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ALGS or BIIB a better investment?
Comparing ALGS and BIIB: Aligos Therapeutics Inc has a market cap of $36.94M while Biogen Inc has $28.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ALGS and BIIB?
ALGS (Aligos Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ALGS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ALGS or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.7% for ALGS.
Which company is more profitable: ALGS or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -3077.2% for ALGS.
Which is the larger company: ALGS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $28.53B compared to $36.94M for ALGS.
Should I buy ALGS or BIIB in 2026?
Both ALGS and BIIB have investment merit. ALGS trades at $6.00 while BIIB trades at $189.28. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ALGS and BIIB stock?
Key differences: Market Cap ($36.94M vs $28.53B), P/E Ratio (N/A vs 20.9x), Revenue Growth (-0.7% vs -0.1%), Gross Margin (-3077.2% vs 78.9%).